Catalyst Wire Dossier Catalyst Wire Dossier

Arbaclofen placarbil

arbaclofen placarbil · Indivior Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Arbaclofen placarbil, covering 2017-01-23 to 2021-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis [Phase 3]

See pricing